Lowest Price Guaranteed
Pages
199
Last Updated
April 2026
View Count
19956
1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Introduction to DNA Synthesis
3.3. Components of DNA Synthesis
3.3.1. Substrates
3.3.2. Template
3.3.3. Primer
3.3.4. Enzymes
3.3.5. Leading Strand Synthesis
3.3.6. Lagging Strand Synthesis
3.4. DNA Synthesis Technologies
3.4.1. Chemical Method of DNA Synthesis
3.4.2. Enzymatic Method of DNA Synthesis
3.5. Applications of DNA Synthesis
3.6. Future Perspectives
4. MARKET OVERVIEW: DNA SYNTHESIS TECHNOLOGIES AND SERVICES
4.1. Chapter Overview
4.2. DNA Synthesis Technologies and Services: Overall Market Landscape
4.2.1. Analysis by Type of Offering
4.2.2. Analysis by Method of DNA Synthesis
4.2.3. Analysis by Type of DNA Molecule
4.2.4. Analysis by Custom Offerings
4.2.5. Analysis by Application Area
4.3. DNA Synthesis Technologies and Services: Key Industry Players
4.3.1 Analysis by Year of Establishment
4.3.2 Analysis by Company Size
4.3.3. Analysis by Location of Headquarters
4.3.4. Analysis by Application Area and Region
5. COMPANY PROFILES
5.1. Chapter Overview
5.2. Ajinomoto Bio-Pharma Services
5.2.1. Company Overview
5.2.2. Financial Information
5.2.3. Technology / Service Portfolio
5.2.4. Recent Developments and Future Outlook
5.3. ATUM
5.3.1. Company overview
5.3.2. Technology / Service Portfolio
5.3.3. Recent Developments and Future Outlook
5.4. DNA Script
5.4.1. Company Overview
5.4.2. Technology / Service Portfolio
5.4.3. Recent Developments and Future Outlook
5.5. Eurofins Genomics
5.5.1. Company Overview
5.5.2. Financial Information
5.5.3. Technology / Service Portfolio
5.5.4. Recent Developments and Future Outlook
5.6. Gene Universal
5.6.1. Company Overview
5.6.2. Technology / Service Portfolio
5.6.3. Recent Developments and Future Outlook
5.7. GenScript
5.7.1. Company Overview
5.7.2. Financial Information
5.7.3. Technology / Service Portfolio
5.7.4. Recent Developments and Future Outlook
5.8. Synbio Technologies
5.8.1. Company overview
5.8.2. Technology / Service Portfolio
5.8.3. Recent Developments and Future Outlook
6. CASE STUDY: OLIGONUCLEOTIDE MANUFACTURERES (RESEARCH AND DIAGNOSTIC APPLICATIONS)
6.1. Chapter Overview
6.2. Oligonucleotide Manufacturers Focused on Research and Diagnostic Applications: Overall Market Landscape
6.2.1. Analysis by Year of Establishment
6.2.2. Analysis by Company Size
6.2.3. Analysis by Scale of Operation
6.2.4. Analysis by Geographical Location
6.2.5. Analysis by Location of Manufacturing Facilities
6.2.6. Analysis by Regulatory Accreditations / Certifications Received
6.2.7. Analysis by Type of Oligonucleotide Manufactured
6.2.8. Analysis by Type of Offering
6.2.9. Analysis by Type of Manufacturing Service Offered
6.2.10. Analysis by Type of Modification
7. CASE STUDY: OLIGONUCLEOTIDE MANUFACTURERES (THERAPEUTIC APPLICATIONS)
7.1. Chapter Overview
7.2. Oligonucleotide Manufacturers Focused on Therapeutic Applications: Overall Market Landscape
7.2.1. Analysis by Year of Establishment
7.2.2. Analysis by Company Size
7.2.3. Analysis by Scale of Operation
7.2.4. Analysis by Geographical Location
7.2.5. Analysis by Location of Manufacturing Facilities
7.2.6. Analysis by Regulatory Accreditations / Certifications
7.2.7. Analysis by Type of Oligonucleotide Manufactured
7.2.8. Analysis by Type of Offering
7.2.9. Analysis by Type of Manufacturing Service Offered
7.2.10. Analysis by Type of Modification
8. PARTNERSHIPS AND COLLABORATIONS
8.1. Chapter Overview
8.2. Partnership Models
8.3. DNA Synthesis Technologies and Services: List of Partnerships and Collaborations
8.3.1. Analysis by Year of Partnership
8.3.2. Analysis by Type of Partnership
8.3.3. Analysis by Type of Partner
8.3.4. Analysis by Year and Type of Partner
8.3.5. Most Active Players: Analysis by Number of Partnerships
8.3.6. Regional Analysis
8.3.6.1. Intercontinental and Intracontinental Agreements
9. FUNDING AND INVESTMENT ANALYSIS
9.1. Chapter Overview
9.2. Types of Funding
9.3. DNA Synthesis Technologies: Recent Funding Instances
9.4. Analysis by Year of Investment
9.5. Analysis by Amount Invested
9.5. Analysis by Amount Invested
9.6. Analysis by Type of Funding and Amount Invested
9.7. Analysis by Venture Capital Funding
9.8. Most Active Players: Analysis by Number of Funding Instances
9.9. Key Investors: Analysis by Number of Funding Instances
9.10. Regional Analysis by Amount Invested
9.11. Funding and Investment Summary
10. GRANT ANALYSIS
10.1 Chapter Overview
10.2. Analysis Methodology and Key Parameters
10.3. DNA Synthesis Technologies and Services: List of Academic Grants
10.3.1. Analysis by Year of Grant Award
10.3.2. Analysis by Grant Amount Awarded
10.3.3. Analysis by Administering Institute Center
10.3.4. Analysis by Support Period
10.3.5. Analysis by Administering Institute Center and Support Period
10.3.6. Analysis by Type of Grant Application
10.3.7. Analysis by Grant Activity Code
10.3.8. Word Cloud of Study Titles
10.3.9. Analysis by Purpose of Grant Award
10.3.10. Popular NIH Departments: Analysis by Number of Grants
10.3.11. Analysis by Type of Recipient Organization
10..12. Prominent Program Officers: Analysis by Number of Grants
11. PUBLICATION ANALYSIS
11.1. Chapter Overview
11.2. Analysis Methodology and Key Parameters
11.3. Analysis by Year of Publication
11.4. Analysis by Quarterly Distribution of Publication
11.5. Analysis by Type of Article
11.6. Analysis by Popular Keywords
11.7. Most Popular Authors: Analysis by Number of Publications
11.8. Popular Publishers: Analysis by Number of Publications
11.9. Popular Journals: Analysis by Number of Publications
11.10. Analysis by Therapeutic Area
11.11. Geographical Analysis
12. PATENT ANALYSIS
12.1. Chapter Overview
12.2. Analysis Methodology and Key Parameters
12.3. DNA Synthesis Technologies and Services: Patent Analysis
12.3.1. Analysis by Type of Patent
12.3.2. Analysis by Publication Year
12.3.3. Analysis by Type of Patent and Publication Year
12.3.3. Analysis by Issuing Authority
12.3.4. Analysis by CPC Symbols
12.3.5. Analysis by Type of Applicant
12.3.6. Word Cloud Analysis: Emerging Focus Areas
12.3.7. Leading Industry Players: Analysis by Number of Patents
12.3.8. Leading Non-Industry Players: Analysis by Number of Patents
12.3.9. Leading Players: Analysis by Number of Patents
12.3.10. Leading Patents: International Patents
12.3.11. Analysis by Patent Characteristics
12.3.12. Patent Valuation Analysis
13. DNA SYNTHESIS SERVICES: MARKET FORECAST AND OPPORTUNITY ANALYSIS
13.1 Chapter Overview
13.2. Key Assumptions and Forecast Methodology
13.3. Global DNA Synthesis Services Market, 2022-2035
13.3.1. Global DNA Synthesis Services Market: Distribution by Method of DNA Synthesis, 2022-2035
13.3.2. Global DNA Synthesis Services Market: Distribution by Application Area, 2022-2035
13.3.3. Global DNA Synthesis Services Market: Distribution by Company Size, 2022-2035
13.3.4. Global DNA Synthesis Services Market: Distribution by Geography, 2022-2035
13.4. DNA Synthesis Services Market in North America, 2022-2035
13.4.1. DNA Synthesis Services Market in North America: Distribution by Method of DNA Synthesis, 2022-2035
13.4.2. DNA Synthesis Services Market in North America: Distribution by Application Area, 2022-2035
13.4.3. DNA Synthesis Services Market in North America: Distribution by Company Size, 2022-2035
13.5. DNA Synthesis Services Market in Europe, 2022-2035
13.5.1. DNA Synthesis Services Market in Europe: Distribution by Method of DNA Synthesis, 2022-2035
13.5.2. DNA Synthesis Services Market in Europe: Distribution by Application Area, 2022-2035
13.5.3. DNA Synthesis Services Market in Europe: Distribution by Company Size, 2022-2035
13.6. DNA Synthesis Services Market in Asia-Pacific and Rest of the World, 2022-2035
13.6.1. DNA Synthesis Services Market in Asia-Pacific and Rest of the World: Distribution by Method of DNA Synthesis, 2022-2035
13.6.2. DNA Synthesis Services Market in Asia-Pacific and Rest of the World: Distribution by Application Area, 2022-2035
13.6.3. DNA Synthesis Services Market in Asia-Pacific and Rest of the World: Distribution by Company Size, 2022-2035
14. CONCLUDING REMARKS
15. APPENDIX 1: TABULATED DATA
16. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS
Figure 3.1 DNA Synthesis 5’ to 3’
Figure 3.2 DNA Synthesis: Direction of Fork Movement
Figure 3.3 Leading Strand Synthesis
Figure 3.4 Lagging Strand Synthesis
Figure 3.5 Applications of DNA Synthesis
Figure 4.1 DNA Synthesis Technologies and Services: Distribution by Type of Offering
Figure 4.2 DNA Synthesis Technologies and Services: Distribution by Method of DNA Synthesis
Figure 4.3 DNA Synthesis Technologies and Services: Distribution by Type of DNA Molecule
Figure 4.4 DNA Synthesis Technologies and Services: Distribution by Custom Offerings
Figure 4.5 DNA Synthesis Technologies and Services: Distribution by Application Area
Figure 4.6 DNA Synthesis Technologies and Service Providers: Distribution by Year of Establishment
Figure 4.7 DNA Synthesis Technologies and Service Providers: Distribution by Company Size
Figure 4.8 DNA Synthesis Technologies and Service Providers: Distribution by Location of Headquarters
Figure 4.9 DNA Synthesis Technologies and Service Providers: Distribution by Application Area and Region
Figure 5.1 Ajinomoto Bio-Pharma Services: Annual Revenues FY 2018- H1 2021 (JPY Billion)
Figure 5.2 Eurofins Genomics: Annual Revenues FY 2018- FY 2021 (JPY Billion)
Figure 5.3 GenScript: Annual Revenues, FY 2018- H1 2021 (USD Billion)
Figure 6.1 Oligonucleotide Manufacturers Focused on Research and Diagnostic Applications: Distribution by Year of Establishment
Figure 6.2 Oligonucleotide Manufacturers Focused on Research and Diagnostic Applications: Distribution by Company Size
Figure 6.3 Oligonucleotide Manufacturers Focused on Research and Diagnostic Applications: Distribution by Scale of Operation
Figure 6.4 Oligonucleotide Manufacturers Focused on Research and Diagnostic Applications: Distribution by Geographical Location
Figure 6.5 Oligonucleotide Manufacturers Focused on Research and Diagnostic Applications: Distribution by Location of Manufacturing Facilities (Country-wise)
Figure 6.6 Oligonucleotide Manufacturers Focused on Research and Diagnostic Applications: Distribution by Regulatory Accreditations / Certifications
Figure 6.7 Oligonucleotide Manufacturers Focused on Research and Diagnostic Applications: Distribution by Type of Oligonucleotide Manufactured
Figure 6.8 Oligonucleotide Manufacturers Focused on Research and Diagnostic Applications: Distribution by Type of Offering
Figure 6.9 Oligonucleotide Manufacturers Focused on Research and Diagnostic Applications: Distribution by Company Size and Type of Offering
Figure 6.10 Oligonucleotide Manufacturers Focused on Research and Diagnostic Applications: Distribution by Type of Oligonucleotide Manufactured and Type of Offering (Custom Synthesis)
Figure 6.11 Oligonucleotide Manufacturers Focused on Research and Diagnostic Applications: Distribution by Type of Manufacturing Service(s) Offered
Figure 7.1 Oligonucleotide Manufacturers Focused on Therapeutic Applications: Distribution by Year of Establishment
Figure 7.2 Oligonucleotide Manufacturers Focused on Therapeutic Applications: Distribution by Company Size
Figure 7.3 Oligonucleotide Manufacturers Focused on Therapeutic Applications: Distribution by Scale of Operation
Figure 7.5 Oligonucleotide Manufacturers Focused on Therapeutic Applications: Distribution by Geographical Location
Figure 7.6 Oligonucleotide Manufacturers Focused on Therapeutic Applications: Distribution by Location of Manufacturing Facilities (Country-wise)
Figure 7.7 Oligonucleotide Manufacturers Focused on Therapeutic Applications: Distribution by Regulatory Accreditations / Certifications
Figure 7.8 Oligonucleotide Manufacturers Focused on Therapeutic Applications: Distribution by Type of Oligonucleotide Manufactured
Figure 7.9 Oligonucleotide Manufacturers Focused on Therapeutic Applications: Distribution by Type of Offering
Figure 7.10 Oligonucleotide Manufacturers Focused on Therapeutic Applications: Distribution by Company Size and Type of Offering
Figure 7.11 Oligonucleotide Manufacturers Focused on Therapeutic Applications: Distribution by Type of Oligonucleotide Manufactured and Type of Offering (Modification)
Figure 7.13 Oligonucleotide Manufacturers Focused on Therapeutic Applications: Distribution by Type of Manufacturing Service (s) Offered
Figure 8.1 Partnerships and Collaborations: Cumulative Year-wise Trend, 2017-2022
Figure 8.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 8.3 Partnerships and Collaborations: Distribution by Type of Partner
Figure 8.4 Partnerships and Collaborations: Distribution by Year and Type of Partner
Figure 8.5 Partnerships and Collaborations: Distribution by Year and Type of Partnership, 2017-2022
Figure 8.6 Most Active Players: Distribution by Number of Partnerships
Figure 8.7 Partnerships and Collaborations: Regional Distribution
Figure 8.8 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 9.1 DNA Synthesis Technologies: Cumulative Distribution by Year of Investment, 2017-2022
Figure 9.2 DNA Synthesis Technologies: Cumulative Amount Invested by Year, 2017- 2022 (USD Million)
Figure 9.3 Funding and Investments: Distribution by Type of Funding
Figure 9.4 Funding and Investments: Distribution of Amount Invested by Type of Funding (USD Million)
Figure 9.5 Funding and Investments: Distribution by Type of Venture Capital Funding
Figure 9.6 Most Active Players: Distribution by Number of Funding Instances
Figure 9.7 Most Active Players: Distribution by Amount Raised, 2017-2022 (USD Million)
Figure 9.8 Funding and Investments: Distribution of Investors by Number of Instances
Figure 9.9 Funding and Investments: Regional Distribution by Amount Invested, 2017-2022
Figure 9.10 Summary of Funding and Investments
Figure 10.1. Grant Analysis: Distribution by Year of Grant Award (FY 2017 – Q1 2022)
Figure 10.2. Grant Analysis: Distribution by Grant Amount Awarded (USD Million)
Figure 10.3. Grant Analysis: Distribution by Administering Institute Center
Figure 10.4. Grant Analysis: Distribution by Support Period
Figure 10.5. Grant Analysis: Distribution by Administering Institute Center and Support Period
Figure 10.6. Grant Analysis: Distribution by Type of Grant Application
Figure 10.7. Grant Analysis: Distribution by Grant Activity Code
Figure 10.8. Word Cloud Analysis: Emerging Focus Areas
Figure 10.9. Grant Analysis: Distribution by Purpose of Grant Award
Figure 10.10. Popular NIH Departments: Distribution by Number of Grants
Figure 10.11. Grant Analysis: Distribution by Type of Recipient Organization
Figure 10.12. Prominent Program Officers: Distribution by Number of Grants
Figure 11.1 Publication Analysis: Cumulative Year-wise Trend, 2017-2022
Figure 11.2 Publication Analysis: Quarterly Distribution of Publications, 2017-2022
Figure 11.3 Publication Analysis: Distribution by Type of Article
Figure 11.4 Word Cloud Analysis: Emerging Focus Areas
Figure 11.5 Analysis by Popular Keywords
Figure 11.6 Most Popular Authors: Distribution by Number of Publications
Figure 11.7 Popular Publishers: Distribution by Number of Publications
Figure 11.8 Popular Journals: Distribution by Number of Publications
Figure 11.9 Publication Analysis: Distribution by Therapeutic Area
Figure 11.10 Publication Analysis: Distribution by Geography
Figure 12.1 Patent Analysis: Distribution by Type of Patent
Figure 12.2 Patent Analysis: Cumulative Distribution by Publication Year (Pre-2017, Q1 2022)
Figure 12.3 Patent Analysis: Year-wise Distribution of Granted Patents, Pre-2017, Q1 2022
Figure 12.4 Patent Analysis: Year-wise Distribution of Filed Patents, Pre-2017, Q1 2022
Figure 12.5 Patent Analysis: Distribution by Type of Patent and Publication Year
Figure 12.6 Patent Analysis: Distribution by Issuing Authority
Figure 12.7 Patent Analysis: Distribution by CPC Symbols
Figure 12.8 Patent Analysis: Cumulative Year-wise Distribution by Type of Applicant
Figure 12.9 Word Cloud Analysis: Emerging Focus Areas
Figure 12.10 Leading Industry Players: Distribution by Number of Patents
Figure 12.11 Leading Non-Industry Players: Distribution by Number of Patents
Figure 12.12 Patent Analysis: Distribution by Patent Age
Figure 12.13 Patent Analysis: Distribution by Relative Valuation
Figure 13.1 Global DNA Synthesis Services Market: Distribution by Method of DNA Synthesis, 2022-2035 (USD Million)
Figure 13.2 Global DNA Synthesis Services Market: Distribution by Company Size, 2022-2035 (USD Million)
Figure 13.3 Global DNA Synthesis Services Market: Distribution by Application Area, 2022-2035 (USD Million)
Figure 13.4 Global DNA Synthesis Services Market: Distribution by Geography, 2022-2035 (USD Million)
Figure 13.5 DNA Synthesis Services Market in North America, 2022-2035 (USD Million)
Figure 13.6 DNA Synthesis Services Market in North America: Distribution by Method of DNA Synthesis, 2022-2035 (USD Million)
Figure 13.7 DNA Synthesis Services Market in North America: Distribution by Application Area, 2022-2035 (USD Million)
Figure 13.8 DNA Synthesis Services Market in North America: Distribution by Company Size, 2022-2035 (USD Million)
Figure 13.9 DNA Synthesis Services Market in Europe, 2022-2035 (USD Million)
Figure 13.10 DNA Synthesis Services Market in Europe: Distribution by Method of DNA Synthesis, 2022-2035 (USD Million)
Figure 13.11 DNA Synthesis Services Market in Europe: Distribution by Application Area, 2022-2035 (USD Million)
Figure 13.12 DNA Synthesis Services Market in Europe: Distribution by Company Size, 2022-2035 (USD Million)
Figure 13.13 DNA Synthesis Services Market in Asia-Pacific and Rest of the World, 2022- 2035 (USD Million)
Figure 13.14 DNA Synthesis Services Market in Asia-Pacific and Rest of the World: Distribution by Method of DNA Synthesis, 2022-2035 (USD Million)
Figure 13.15 DNA Synthesis Services Market in Asia-Pacific and Rest of the World: Distribution by Application Area, 2022-2035 (USD Million)
Figure 13.16 DNA Synthesis Services Market in Asia-Pacific and Rest of the World: Distribution by Company Size, 2022-2035 (USD Million)
Figure 14.1 Concluding Remarks: Overall Market Landscape of DNA Synthesis Technologies and Services
Figure 14.2 Concluding Remarks: Partnerships and Collaborations
Figure 14.3 Concluding Remarks: Funding and Investments
Figure 14.4 Concluding Remarks: Grant Analysis
Figure 14.5 Concluding Remarks: Publication Analysis
Figure 14.6 Concluding Remarks: Patent Analysis
Table 4.1 DNA Synthesis Technologies and Services: Information on Developers, Type of Offering, Method of DNA Synthesis, Type of DNA Molecule, Custom Offerings and Type of Application Area
Table 4.2 DNA Synthesis Technologies and Services Providers: Information on Year of Establishment, Company Size and Geography
Table 5.1 DNA Synthesis Technology and Service Providers: List of Companies Profiled
Table 5.2 Ajinomoto Bio-Pharma Services: Company Snapshot
Table 5.3 Ajinomoto Bio-Pharma Services: Technology / Service Portfolio
Table 5.4 Ajinomoto Bio-Pharma Services: Recent Developments and Future Outlook
Table 5.5 ATUM: Company Snapshot
Table 5.6 ATUM: Technology / Service Portfolio
Table 5.7 DNA Script: Company Snapshot
Table 5.8 DNA Script: Technology / Service Portfolio
Table 5.9 DNA Script: Recent Developments and Future Outlook
Table 5.10 Eurofins Genomics: Company Snapshot
Table 5.11 Eurofins Genomics: Technology / Service Portfolio
Table 5.12 Gene Universal: Company Snapshot
Table 5.13 Gene Universal: Technology / Service Portfolio
Table 5.14 GenScript: Company Snapshot
Table 5.15 GenScript Technology / Service Portfolio
Table 5.16 GenScript: Recent Developments and Future Outlook
Table 5.17 Synbio Technologies: Company Snapshot
Table 5.18 Synbio Technologies: Technology / Service Portfolio
Table 6.1 Oligonucleotide Manufacturers Focused on Research and Diagnostic Applications: List of Industry Players
Table 6.2 Oligonucleotide Manufacturers Focused on Research and Diagnostic Applications: Information on Location of Manufacturing Facilities and Regulatory Accreditations / Certifications
Table 6.3 Oligonucleotide Manufacturers Focused on Research and Diagnostic Applications: Information on Type of Oligonucleotide Manufactured and Type of Service(s) Offered
Table 6.4 Oligonucleotide Manufacturers Focused on Research and Diagnostic Applications: Information on Type of Manufacturing Service(s) Offered
Table 6.5 Oligonucleotide Manufacturers Focused on Research and Diagnostic Applications: Information on Type of Modification(s) and Type of Purification Method(s) Used
Table 7.1 Oligonucleotide Manufacturers Focused on Therapeutic Applications: List of Industry Players
Table 7.2 Oligonucleotide Manufacturers Focused on Therapeutic Applications: Information on Location of Manufacturing Facilities and Regulatory Accreditations / Certifications
Table 7.3 Oligonucleotide Manufacturers Focused on Therapeutic Applications: Information on Type of Oligonucleotide Manufactured and Type of Offering
Table 7.4 Oligonucleotide Manufacturers Focused on Therapeutic Applications: Information on Type of Manufacturing Service(s) Offered
Table 7.5 Oligonucleotide Manufacturers Focused on Therapeutic Applications: Information on Type of Modification(s) and Type of Purification Method(s) Used
Table 8.1 DNA Synthesis Technologies and Services Providers: List of Partnerships and Collaborations, 2017-2022 (till March)
Table 9.1 DNA Synthesis Technologies: List of Funding Instances, 2017-2022 (till March)
Table 9.2 Funding and Investment Analysis: Summary of Investments
Table 10.1 DNA Synthesis Technologies and Services: List of Academic Grants
Table 12.1 Patent Analysis: CPC Symbols
Table 12.2 Patent Analysis: Most Popular CPC Symbols
Table 12.3 Patent Analysis: List of Top 10 CPC Symbols
Table 12.4 Patent Analysis: List of Relatively High Value Patents
Table 16.1 DNA Synthesis Technologies and Services: Distribution by Type of Offering
Table 16.2 DNA Synthesis Technologies and Services: Distribution by Method of DNA Synthesis
Table 16.3 DNA Synthesis Technologies and Services: Distribution by Type of DNA Molecule
Table 16.4 DNA Synthesis Technologies and Services: Distribution by Custom Synthesis
Table 16.5 DNA Synthesis Technologies and Services: Distribution by Application Area
Table 16.6 DNA Synthesis Technologies and Service Providers: Distribution by Year of Establishment
Table 16.7 DNA Synthesis Technologies and Service Providers: Distribution by Company Size
Table 16.8 DNA Synthesis Technologies and Service Providers Distribution by Location of Headquarters
Table 16.9 DNA Synthesis Technologies and Service Providers Distribution by Application and Region
Table 16.10 Ajinomoto Bio-Pharma Services: Annual Revenues FY 2018- H1 2021 (JPY Billion)
Table 16.11 Eurofins Genomics: Annual Revenues FY 2018- H1 2021 (JPY Billion)
Table 16.12 GenScript: Annual Revenues, FY 2018- H1 2021 (USD Billion)
Table 16.13 Oligonucleotide Manufacturers Focused on Research and Diagnostic Applications: Distribution by Year of Establishment
Table 16.14 Oligonucleotide Manufacturers Focused on Research and Diagnostic Applications: Distribution by Company Size
Table 16.15 Oligonucleotide Manufacturers Focused on Research and Diagnostic Applications: Distribution by Scale of Operation
Table 16.16 Oligonucleotide Manufacturers Focused on Research and Diagnostic Applications: Distribution by Location of Headquarters
Table 16.17 Oligonucleotide Manufacturers Focused on Research and Diagnostic Applications: Distribution by Location of Manufacturing Facilities (Country-wise)
Table 16.18 Oligonucleotide Manufacturers Focused on Research and Diagnostic Applications: Distribution by Regulatory Accreditations / Certifications
Table 16.19 Oligonucleotide Manufacturers Focused on Research and Diagnostic Applications: Distribution by Type of Oligonucleotide Manufactured
Table 16.20 Oligonucleotide Manufacturers Focused on Research and Diagnostic Applications: Distribution by Type of Offering
Table 16.21 Oligonucleotide Manufacturers Focused on Research and Diagnostic Applications: Distribution by Company Size and Type of Offering
Table 16.22 Oligonucleotide Manufacturers Focused on Research and Diagnostic Applications: Distribution by Type of Oligonucleotide Manufactured and Type of Offering (Custom Synthesis)
Table 16.23 Oligonucleotide Manufacturers Focused on Research and Diagnostic Applications: Distribution by Type of Manufacturing Service(s) Offered
Table 16.24 Oligonucleotide Manufacturers Focused on Therapeutic Applications: Distribution by Year of Establishment
Table 16.25 Oligonucleotide Manufacturers Focused on Therapeutic Applications: Distribution by Company Size
Table 16.26 Oligonucleotide Manufacturers Focused on Therapeutic Applications: Distribution by Scale of Operation
Table 16.27 Oligonucleotide Manufacturers Focused on Therapeutic Applications: Distribution by Location of Headquarters6
Table 16.28 Oligonucleotide Manufacturers Focused on Therapeutic Applications: Distribution by Location of Manufacturing Facilities (Country-wise)
Table 16.29 Oligonucleotide Manufacturers Focused on Therapeutic Applications: Distribution by Regulatory Accreditations / Certifications
Table 16.30 Oligonucleotide Manufacturers Focused on Therapeutic Applications: Distribution by Type of Oligonucleotide Manufactured
Table 16.31 Oligonucleotide Manufacturers Focused on Therapeutic Applications: Distribution by Type of Offering
Table 16.32 Oligonucleotide Manufacturers Focused on Therapeutic Applications: Distribution by Company Size and Type of Offering16
Table 16.33 Oligonucleotide Manufacturers Focused on Therapeutic Applications: Distribution by Type of Oligonucleotide Manufactured and Type of Offering (Modification)
Table 16.34 Oligonucleotide Manufacturers Focused on Therapeutic Applications: Distribution by Type of Manufacturing Service (s) Offered
Table 16.35 Partnerships and Collaborations: Cumulative Year-wise Trend, 2017-2022
Table 16.36 Partnerships and Collaborations: Distribution by Type of Partnership
Table 16.37 Partnerships and Collaborations: Distribution by Year and Type of Partnership, 2017-2022
Table 16.38 Most Active Players: Distribution by Number of Partnerships
Table 16.39 Partnerships and Collaborations: Distribution by Type of Partner
Table 16.40 Partnerships and Collaborations: Distribution by Year and Type of Partner
Table 16.41 Partnerships and Collaborations: Regional Distribution
Table 16.42 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Table 16.43 DNA Synthesis Technologies: Distribution by Year of Investment, 2017-2022
Table 16.44 DNA Synthesis Technologies: Cumulative Amount Invested by Year, 2017-
2022 (USD Million)
Table 16.45 Funding and Investments: Distribution by Type of Funding
Table 16.46 Funding and Investments: Distribution of Amount Invested by Type of
Funding (USD Million)
Table 16.47 Distribution by Type of Venture Capital Funding
Table 16.48 Most Active Players: Distribution by Number of Funding Rounds
Table 16.49 Most Active Players: Distribution by Amount Raised 2017-2022 (USD
Million)
Table 16.50 Funding and Investment: Distribution of investors by number of instances
Table 16.51 Funding and Investment Analysis: Regional Distribution of Total Amount
Invested, 2017-2022
Table 16.52 Grant Analysis: Distribution by Year of Grant Award
Table 16.53 Grant Analysis: Distribution by Grant Amount Awarded
Table 16.54 Grant Analysis: Distribution by Administering Institute Center
Table 16.55 Grant Analysis: Distribution by Support Period
Table 16.56 Grant Analysis: Distribution by Administering Institute Center and Support
Year
Table 16.57 Grant Analysis: Distribution by Type of Grant Application
Table 16.58 Grant Analysis: Distribution by Grant Activity Code
Table 16.59 Grant Analysis: Word Cloud of Study Titles
Table 16.60 Grant Analysis: Distribution by Purpose of Grant Award
Table 16.61 Grant Analysis: Distribution by Type of Recipient Organization
Table 16.62 Popular NIH Departments: Distribution by Number of Grants
Table 16.63 Prominent Program Officers: Distribution by Number of Grants
Table 16.64 Publication Analysis: Cumulative Year-wise Trend, 2017-2022
Table 16.65 Publication Analysis: Quarterly Distribution of Publications
Table 16.66 Publication Analysis: Distribution by Type of Article
Table 16.67 Publication Analysis: Word Cloud of Study Titles
Table 16.68 Analysis by Popular Keywords
Table 16.69 Most Popular Authors: Distribution by Number of Publications
Table 16.70 Popular Publishers: Distribution by Number of Publications
Table 16.71 Popular Journals: Distribution by Number of Publications
Table 16.72 Popular Journals: Distribution by Number of Publications
Table 16.73 Publication Analysis: Distribution by Geography
Table 16.74 Patent Analysis: Distribution by Type of Patent
Table 16.75 Patent Analysis: Cumulative Distribution by Publication Year
Table 16.76 Patent Analysis: Distribution of Granted Patents by Publication Year
Table 16.77 Patent Analysis: Distribution of Filed Patents Publication Year
Table 16.78 Patent Analysis: Distribution by Type of Patent and Publication Year
Table 16.79 Patent Analysis: Distribution by Issuing Authority
Table 16.80 Patent Analysis: Cumulative Year-wise Distribution by Type of Applicant
Table 16.81 Leading Industry Players: Distribution by Number of Patents
Table 16.82 Leading Non-Industry Players: Distribution by Number of Patents
Table 16.83 Patent Analysis: Distribution by Patent Age
Table 16.84 Patent Analysis: Distribution by Relative Valuation
Table 16.85 Global DNA Synthesis Services Market: Distribution by Method of DNA Synthesis, 2022-2035 (USD Million)
Table 16.86 Global DNA Synthesis Services Market: Distribution by Company Size, 2022-2035 (USD Million)
Table 16.87 Global DNA Synthesis Services Market: Distribution by Company Size, 2022-2035 (USD Million)
Table 16.88 Global DNA Synthesis Services Market: Distribution by Type of Application Area, 2022-2035 (USD Million)
Table 16.89 Global DNA Synthesis Services Market: Distribution by Geography, 2022-2035 (USD Million)
Table 16.90 DNA Synthesis Services Market in North America, 2022-2035 (USD Million)
Table 16.91 DNA Synthesis Services Market in North America: Distribution by Method of DNA Synthesis, 2022-2035 (USD Million)
Table 16.92 DNA Synthesis Services Market in North America: Distribution by Type of Application Area , 2022-2035 (USD Million)
Table 16.93 DNA Synthesis Services Market in North America: Distribution by Company Size, 2022-2035 (USD Million)
Table 16.94 DNA Synthesis Services Market in Europe, 2022-2035 (USD Million)
Table 16.95 DNA Synthesis Services Market in Europe: Distribution by Method of DNA Synthesis, 2022-2035 (USD Million)
Table 16.96 DNA Synthesis Services Market in Europe: Distribution by Type of Application Area, 2022-2035 (USD Million)
Table 16.97 DNA Synthesis Services Market in Europe: Distribution by Company Size, 2022-2035 (USD Million)
Table 16.98 DNA Synthesis Services Market in Asia-Pacific and Rest of the World, 2022- 2035 (USD Million)
Table 16.99 DNA Synthesis Services Market in Asia-Pacific and Rest of the World: Distribution by Method of DNA Synthesis, 2022-2035 (USD Million)
Table 16.100 DNA Synthesis Services Market in Asia-Pacific and Rest of the World: Distribution by Type of Application Area, 2022-2035 (USD Million)
Table 16.101 DNA Synthesis Services Market in Asia-Pacific and Rest of the World: Distribution by Company Size, 2022-2035 (USD Million)
Please reach out to our team for the details.